PARVG | parvin, gamma | 22q13.31 | 0.355 | 0.36 | 1.94e-14
|
GAB3 | GRB2-associated binding protein 3 | Xq28 | 0.351 | 0.355 | 5.26e-14
|
STAB1 | stabilin 1 | 3p21.31 | 0.347 | 0.255 | 1.07e-07
|
IQGAP2 | IQ motif containing GTPase activating protein 2 | 5q | 0.346 | 0.383 | 9.05e-17
|
JAK3 | Janus kinase 3 | 19p13-p12 | 0.343 | 0.214 | 8.17e-06
|
GYPC | glycophorin C (Gerbich blood group) | 2q14-q21 | 0.342 | 0.288 | 1.54e-09
|
TMEM176A | transmembrane protein 176A | 7q36.1 | 0.338 | 0.302 | 2.2e-10
|
IFFO1 | intermediate filament family orphan 1 | 12p13.31 | 0.337 | 0.264 | 3.51e-08
|
EVI2B | ecotropic viral integration site 2B | 17q11.2 | 0.336 | 0.327 | 5.41e-12
|
NCKAP1L | NCK-associated protein 1-like | 12q13.1 | 0.334 | 0.358 | 2.83e-14
|
PLEKHO2 | pleckstrin homology domain containing, family O member 2 | 15q22.31 | 0.333 | 0.295 | 6e-10
|
EVI2A | ecotropic viral integration site 2A | 17q11.2 | 0.333 | 0.319 | 1.93e-11
|
FOLR2 | folate receptor 2 (fetal) | 11q13.3-q14.1 | 0.332 | 0.267 | 2.35e-08
|
BTK | Bruton agammaglobulinemia tyrosine kinase | Xq21.33-q22 | 0.331 | 0.328 | 4.74e-12
|
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 7p12.2 | 0.331 | 0.4 | 0
|
CMAHP | cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene | 6p23-p22 | 0.331 | 0.268 | 2.07e-08
|
GIMAP1 | GTPase, IMAP family member 1 | 7q36.1 | 0.331 | 0.293 | 7.66e-10
|
NAPSB | napsin B aspartic peptidase, pseudogene | 19q13.33 | 0.329 | 0.294 | 6.68e-10
|
HRH2 | histamine receptor H2 | 5q35 | 0.328 | 0.407 | 0
|
CD37 | CD37 molecule | 19p13-q13.4 | 0.328 | 0.333 | 2.16e-12
|
MFNG | MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | 22q13.1 | 0.327 | 0.278 | 6.27e-09
|
GIMAP5 | GTPase, IMAP family member 5 | 7q36.1 | 0.325 | 0.288 | 1.61e-09
|
MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 11q12.1 | 0.325 | 0.308 | 9.54e-11
|
TBXAS1 | thromboxane A synthase 1 (platelet) | 7q34-q35 | 0.325 | 0.307 | 1.19e-10
|
WDFY4 | WDFY family member 4 | 10q11.23 | 0.324 | 0.347 | 2.14e-13
|
CPA3 | carboxypeptidase A3 (mast cell) | 3q24 | 0.321 | 0.136 | 0.00502
|
GPBAR1 | G protein-coupled bile acid receptor 1 | 2q35 | 0.319 | 0.201 | 2.85e-05
|
RASGEF1B | RasGEF domain family, member 1B | 4q21.21 | 0.317 | 0.474 | 0
|
DOCK2 | dedicator of cytokinesis 2 | 5q35.1 | 0.316 | 0.379 | 3.14e-16
|
IL10RA | interleukin 10 receptor, alpha | 11q23 | 0.315 | 0.341 | 6.34e-13
|
TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 9q33 | 0.315 | 0.333 | 2.31e-12
|
PLD4 | phospholipase D family, member 4 | 14q32.33 | 0.314 | 0.242 | 4.57e-07
|
PECAM1 | platelet/endothelial cell adhesion molecule 1 | 17q23.3 | 0.312 | 0.179 | 0.000206
|
ARHGAP31 | Rho GTPase activating protein 31 | 3q13.33 | 0.312 | 0.305 | 1.45e-10
|
LY86 | lymphocyte antigen 86 | 6p24.3 | 0.312 | 0.295 | 5.78e-10
|
CD300C | CD300c molecule | 17q25.2 | 0.311 | 0.291 | 1.01e-09
|
AMICA1 | adhesion molecule, interacts with CXADR antigen 1 | 11q23.3 | 0.308 | 0.259 | 6.33e-08
|
PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 17p13.1 | 0.307 | 0.365 | 7.59e-15
|
CXCR3 | chemokine (C-X-C motif) receptor 3 | Xq13 | 0.306 | 0.344 | 3.54e-13
|
OGFRL1 | opioid growth factor receptor-like 1 | 6q13 | 0.303 | 0.472 | 0
|
DPYSL2 | dihydropyrimidinase-like 2 | 8p22-p21 | 0.301 | 0.293 | 8.45e-10
|
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 4q12 | 0.299 | 0.185 | 0.000124
|
GIMAP2 | GTPase, IMAP family member 2 | 7q36.1 | 0.299 | 0.352 | 8.7e-14
|
RASGRP1 | RAS guanyl releasing protein 1 (calcium and DAG-regulated) | 15q15 | 0.299 | 0.402 | 0
|
ITGA9 | integrin, alpha 9 | 3p21.3 | 0.296 | 0.264 | 3.3e-08
|
PAMR1 | peptidase domain containing associated with muscle regeneration 1 | 11p13 | 0.293 | 0.064 | 0.186
|
CELF2 | CUGBP, Elav-like family member 2 | 10p13 | 0.293 | 0.42 | 0
|
OLFM1 | olfactomedin 1 | 9q34.3 | 0.286 | 0.324 | 9.38e-12
|
CNTLN | centlein, centrosomal protein | 9p22.2-p22.1 | 0.285 | 0.396 | 0
|
FAM124A | family with sequence similarity 124A | 13q14.3 | 0.283 | 0.497 | 0
|
S100P | S100 calcium binding protein P | 4p16 | 0.28 | -0.306 | 1.3e-10
|
ZNF385B | zinc finger protein 385B | 2q31.3-q32.1 | 0.279 | 0.45 | 0
|
PLA2G2F | phospholipase A2, group IIF | 1p35 | 0.278 | -0.405 | 0
|
NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 15q24-q25 | 0.276 | 0.285 | 2.42e-09
|
SPEF2 | sperm flagellar 2 | 5p13.2 | 0.275 | 0.394 | 0
|
RORA | RAR-related orphan receptor A | 15q21-q22 | 0.275 | 0.446 | 0
|
POU6F1 | POU class 6 homeobox 1 | 12q13.13 | 0.267 | 0.394 | 0
|
SIMC1 | SUMO-interacting motifs containing 1 | 5q35.2 | 0.267 | 0.381 | 1.92e-16
|
TDG | thymine DNA glycosylase | 12q24.1 | 0.265 | -0.208 | 1.54e-05
|
KCNG3 | potassium channel, voltage gated modifier subfamily G, member 3 | 2p21 | 0.265 | 0.27 | 1.58e-08
|
KHDC1 | KH homology domain containing 1 | 6q13 | 0.264 | 0.35 | 1.27e-13
|
ARMC4 | armadillo repeat containing 4 | 10p12.1 | 0.261 | 0.409 | 0
|
GSPT2 | G1 to S phase transition 2 | Xp11.22 | 0.261 | 0.319 | 1.84e-11
|
CTSS | cathepsin S | 1q21 | 0.261 | 0.276 | 8.15e-09
|
TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 | 6p21.1 | 0.26 | -0.375 | 8.49e-16
|
FMNL2 | formin-like 2 | 2q23.3 | 0.259 | 0.282 | 3.37e-09
|
ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | 17q24 | 0.258 | 0.068 | 0.163
|
CFLAR | CASP8 and FADD-like apoptosis regulator | 2q33-q34 | 0.257 | 0.327 | 5.95e-12
|
CDCA7L | cell division cycle associated 7-like | 7p15.3 | 0.256 | 0.334 | 1.93e-12
|
SRSF12 | serine/arginine-rich splicing factor 12 | 6q16.1 | 0.255 | 0.411 | 0
|
PAQR7 | progestin and adipoQ receptor family member VII | 1p35.3 | 0.251 | -0.282 | 3.46e-09
|
STARD4 | StAR-related lipid transfer (START) domain containing 4 | 5q22 | 0.25 | 0.319 | 1.88e-11
|
GMPR | guanosine monophosphate reductase | 6p23 | 0.25 | 0.415 | 0
|
BEND7 | BEN domain containing 7 | 10p14 | 0.249 | 0.246 | 2.8e-07
|
EXOSC7 | exosome component 7 | 3p21.32 | 0.244 | -0.307 | 1.1e-10
|
WDR17 | WD repeat domain 17 | 4q34 | 0.244 | 0.343 | 4.57e-13
|
SCCPDH | saccharopine dehydrogenase (putative) | 1q44 | 0.243 | -0.283 | 3e-09
|
RNF130 | ring finger protein 130 | 5q35.3 | 0.24 | 0.373 | 1.35e-15
|
GABARAPL1 | GABA(A) receptor-associated protein like 1 | 12p13.31 | 0.238 | 0.231 | 1.55e-06
|
COBL | cordon-bleu WH2 repeat protein | 7p12.2-p12.1 | 0.234 | 0.419 | 0
|
ARHGAP28 | Rho GTPase activating protein 28 | 18p11.23 | 0.233 | 0.393 | 0
|
TH | tyrosine hydroxylase | 11p15.5 | 0.232 | -0.285 | 2.5e-09
|
JADE2 | jade family PHD finger 2 | 5q31.2 | 0.232 | 0.301 | 2.84e-10
|
TMEM220 | transmembrane protein 220 | 17p13.1 | 0.23 | 0.318 | 2.39e-11
|
CCNA1 | cyclin A1 | 13q12.3-q13 | 0.229 | 0.391 | 0
|
CTSO | cathepsin O | 4q32.1 | 0.229 | 0.267 | 2.37e-08
|
UGT8 | UDP glycosyltransferase 8 | 4q26 | 0.228 | 0.312 | 5.22e-11
|
ATP5O | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit | 21q22 | 0.226 | -0.174 | 0.000306
|
RIMKLB | ribosomal modification protein rimK-like family member B | 12p13.31 | 0.225 | 0.407 | 0
|
GSTM3 | glutathione S-transferase mu 3 (brain) | 1p13.3 | 0.224 | -0.136 | 0.00504
|
COL4A4 | collagen, type IV, alpha 4 | 2q35-q37 | 0.224 | 0.392 | 0
|
PRIMA1 | proline rich membrane anchor 1 | 14q32.13 | 0.222 | 0.348 | 1.81e-13
|
ZNF154 | zinc finger protein 154 | 19q13.4 | 0.221 | 0.189 | 8.66e-05
|
PNRC1 | proline-rich nuclear receptor coactivator 1 | 6q16.1 | 0.221 | 0.373 | 1.46e-15
|
TRIM58 | tripartite motif containing 58 | 1q44 | 0.22 | 0.303 | 2.01e-10
|
NINL | ninein-like | 20p11.22-p11.1 | 0.216 | 0.21 | 1.32e-05
|
KDELR1 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 | 19q13.33 | 0.214 | -0.356 | 4.67e-14
|
AUTS2 | autism susceptibility candidate 2 | 7q11.22 | 0.214 | 0.249 | 2.12e-07
|
PLD6 | phospholipase D family, member 6 | 17p11.2 | 0.212 | 0.19 | 7.73e-05
|
CHRFAM7A | CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion | 15q13.2 | 0.212 | 0.422 | 0
|
NOV | nephroblastoma overexpressed | 8q24.12 | 0.211 | 0.155 | 0.00136
|
POFUT2 | protein O-fucosyltransferase 2 | 21q22.3 | 0.21 | -0.223 | 3.52e-06
|
TARBP1 | TAR (HIV-1) RNA binding protein 1 | 1q42.2 | 0.21 | -0.08 | 0.0985
|
AMIGO2 | adhesion molecule with Ig-like domain 2 | 12q13.11 | 0.21 | -0.42 | 0
|
SCLT1 | sodium channel and clathrin linker 1 | 4q28.2 | 0.21 | 0.066 | 0.175
|
SLFN13 | schlafen family member 13 | 17q12 | 0.209 | 0.25 | 1.92e-07
|
CHGB | chromogranin B | 20p12.3 | 0.209 | 0.28 | 4.65e-09
|
ENO2 | enolase 2 (gamma, neuronal) | 12p13 | 0.208 | -0.136 | 0.00491
|
WIPF3 | WAS/WASL interacting protein family, member 3 | 7p15.1 | 0.208 | 0.369 | 3.41e-15
|
LRP4 | low density lipoprotein receptor-related protein 4 | 11p11.2 | 0.207 | -0.26 | 5.48e-08
|
BEGAIN | brain-enriched guanylate kinase-associated | 14q32.2 | 0.206 | 0.237 | 7.52e-07
|
ZNF815P | zinc finger protein 815, pseudogene | 7p22.1 | 0.206 | 0.122 | 0.0116
|
RAVER2 | ribonucleoprotein, PTB-binding 2 | 1p31.3 | 0.206 | 0.228 | 2.03e-06
|
MTL5 | metallothionein-like 5, testis-specific (tesmin) | 11q13.2-q13.3 | 0.205 | 0.071 | 0.146
|
ORAOV1 | oral cancer overexpressed 1 | 11q13.2 | 0.204 | -0.262 | 4.58e-08
|
PCDHAC2 | protocadherin alpha subfamily C, 2 | 5q31 | 0.204 | 0.252 | 1.42e-07
|
IGHMBP2 | immunoglobulin mu binding protein 2 | 11q13.3 | 0.203 | -0.258 | 6.73e-08
|
LINC00908 | long intergenic non-protein coding RNA 908 | 18q23 | 0.203 | 0.276 | 8.09e-09
|
ZNF488 | zinc finger protein 488 | 10q11.22 | 0.202 | -0.327 | 5.42e-12
|
RFX5 | regulatory factor X, 5 (influences HLA class II expression) | 1q21 | 0.201 | 0.312 | 5.3e-11
|
MTFR1 | mitochondrial fission regulator 1 | 8q13.1 | 0.201 | -0.296 | 5.03e-10
|
PARP11 | poly (ADP-ribose) polymerase family, member 11 | 12p13.3 | 0.201 | 0.341 | 5.9e-13
|
LINC00526 | long intergenic non-protein coding RNA 526 | 18p11.31 | 0.199 | 0.19 | 7.78e-05
|
AMDHD1 | amidohydrolase domain containing 1 | 12q23.1 | 0.198 | 0.311 | 6.55e-11
|
C11orf63 | chromosome 11 open reading frame 63 | 11q24.1 | 0.197 | 0.122 | 0.0118
|
TFDP2 | transcription factor Dp-2 (E2F dimerization partner 2) | 3q23 | 0.195 | 0.075 | 0.121
|
DUS2 | dihydrouridine synthase 2 | 16q22.1 | 0.193 | -0.329 | 4.07e-12
|
LINC00669 | MIR924 host gene | 18q12.2-q12.3 | 0.192 | 0.124 | 0.0103
|
C6orf141 | chromosome 6 open reading frame 141 | 6p12.3 | 0.192 | 0.082 | 0.0904
|
KRTAP5-AS1 | KRTAP5-1/KRTAP5-2 antisense RNA 1 | 11p15.5 | 0.19 | 0.2 | 3.28e-05
|
HMGB2 | high mobility group box 2 | 4q31 | 0.189 | 0.001 | 0.978
|
SMPDL3B | sphingomyelin phosphodiesterase, acid-like 3B | 1p35.3 | 0.187 | 0.003 | 0.949
|
LAMB1 | laminin, beta 1 | 7q22 | 0.183 | -0.183 | 0.000144
|
FAM201A | family with sequence similarity 201, member A | 9p12 | 0.181 | 0.242 | 4.48e-07
|
OGDHL | oxoglutarate dehydrogenase-like | 10q11.23 | 0.18 | 0.307 | 1.18e-10
|
TMEM184B | transmembrane protein 184B | 22q12 | 0.178 | -0.291 | 9.99e-10
|
PM20D2 | peptidase M20 domain containing 2 | 6q15 | 0.177 | 0.181 | 0.000179
|
FMO4 | flavin containing monooxygenase 4 | 1q24.3 | 0.175 | 0.279 | 5.49e-09
|
GPR143 | G protein-coupled receptor 143 | Xp22.3 | 0.168 | 0.2 | 3.38e-05
|
C4orf47 | chromosome 4 open reading frame 47 | 4q35.1 | 0.168 | 0.103 | 0.0339
|